Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

756 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Difficult-to-treat rheumatoid arthritis: Current concept and unsolved problems.
Watanabe R, Okano T, Gon T, Yoshida N, Fukumoto K, Yamada S, Hashimoto M. Watanabe R, et al. Among authors: fukumoto k. Front Med (Lausanne). 2022 Oct 24;9:1049875. doi: 10.3389/fmed.2022.1049875. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36353219 Free PMC article. Review.
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study.
Watanabe R, Ebina K, Gon T, Okano T, Murata K, Murakami K, Maeda Y, Jinno S, Shirasugi I, Son Y, Amuro H, Katayama M, Hara R, Hata K, Yoshikawa A, Yamamoto W, Tachibana S, Hayashi S, Etani Y, Katsushima M, Fukumoto K, Yamada S, Hashimoto M. Watanabe R, et al. Among authors: fukumoto k. Rheumatology (Oxford). 2024 May 9:keae265. doi: 10.1093/rheumatology/keae265. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38724245
Addison's Disease Caused by Tuberculosis with Atypical Hyperpigmentation and Active Pulmonary Tuberculosis.
Namikawa H, Takemoto Y, Kainuma S, Umeda S, Makuuchi A, Fukumoto K, Kobayashi M, Kinuhata S, Isaka Y, Toyoda H, Kamata N, Tochino Y, Hiura Y, Morimura M, Shuto T. Namikawa H, et al. Among authors: fukumoto k. Intern Med. 2017;56(14):1843-1847. doi: 10.2169/internalmedicine.56.7976. Epub 2017 Jul 15. Intern Med. 2017. PMID: 28717080 Free PMC article.
Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial.
Tanaka A, Sata M, Okada Y, Teragawa H, Eguchi K, Shimabukuro M, Taguchi I, Matsunaga K, Kanzaki Y, Yoshida H, Ishizu T, Ueda S, Kitakaze M, Murohara T, Node K; PROTECT study investigators. Tanaka A, et al. Eur Heart J Cardiovasc Pharmacother. 2023 Feb 2;9(2):165-172. doi: 10.1093/ehjcvp/pvac059. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36308299 Free PMC article. Clinical Trial.
Effects of ipragliflozin on left ventricular diastolic function in patients with type 2 diabetes: A sub-analysis of the PROTECT trial.
Kusunose K, Imai T, Tanaka A, Doi M, Koide Y, Fukumoto K, Kadokami T, Ohishi M, Teragawa H, Ohte N, Yamada H, Sata M, Node K; PROTECT investigators. Kusunose K, et al. Among authors: fukumoto k. J Cardiol. 2024 Feb 18:S0914-5087(24)00020-0. doi: 10.1016/j.jjcc.2024.02.002. Online ahead of print. J Cardiol. 2024. PMID: 38378130
756 results